Hui‐Li Yang

2.9k citations
63 papers · 2.1k indexed · h-index 28
Topics
Reproductive System and Pregnancy (33 papers)Endometriosis Research and Treatment (28 papers)Endometrial and Cervical Cancer Treatments (10 papers)
Partner nations
ChinaHong KongSingapore

In The Last Decade

Hui‐Li Yang

62 papers receiving 2.1k citations

Peers

Hui‐Li Yang
Comparison fields: 5 of 120
  • Immunology 919
  • Reproductive Medicine 789
  • Molecular Biology 730
  • Obstetrics and Gynecology 641
  • Cancer Research 364
Replace Hsin‐Shih Wang with:
Hsin‐Shih Wang Taiwan
Marie Cohen Switzerland
Maryam Shahhoseini Iran
Nava Nevo Israel
Riccardo Vago Italy
Sandra Schulze Germany
Tianyuan Wang United States
Kin Lam Fok Hong Kong
Rocio Garcı́a-Becerra Mexico
Qiuyang Zhang United States
Hui‐Li Yang relative to Hsin‐Shih Wang Taiwan Hsin‐Shih Wang's profile →
Citations per field
00.5×5.0×
Hsin‐Shih Wang · 1×
Citations per year

Countries citing papers authored by Hui‐Li Yang

Since Specialization
Citations

This map shows the geographic impact of Hui‐Li Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Li Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Li Yang more than expected).

Fields of papers citing papers by Hui‐Li Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Li Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Li Yang. The network helps show where Hui‐Li Yang may publish in the future.

Co-authorship network of co-authors of Hui‐Li Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Li Yang. A scholar is included among the top collaborators of Hui‐Li Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Li Yang. Hui‐Li Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 6
3 6
4 7
5 56
6 18
7 37
8 3
9 3
10 10
11 32
12 65
13 102
14 54
15 42
16 27
17 50
18 58
19 18
20 17

About Hui‐Li Yang

Hui‐Li Yang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Reproductive System and Pregnancy (33 papers), Endometriosis Research and Treatment (28 papers) and Endometrial and Cervical Cancer Treatments (10 papers). The work is most often cited by research in Reproductive Medicine (789 citations), Obstetrics and Gynecology (641 citations) and Immunology (919 citations). Hui‐Li Yang has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Ming‐Qing Li, Wen‐Jie Zhou, Jie Mei, Kai‐Kai Chang, Da‐Jin Li, Zhen‐Zhen Lai, Jun Shao, Jiawei Shi, Xuemin Qiu and Siyao Ha. Their work appears in journals such as The EMBO Journal, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026